{
   "hash" : "1235b6a25a99935ccccdcc625684d69b1678c31d",
   "keywords_main" : "U.S. Food and Drug Administration",
   "keywords" : [
      {
         "name" : "RAS inhibitor",
         "index" : 115,
         "slug" : "/wiki/ras%20gtpase#ras%20inhibitors"
      },
      {
         "index" : 1,
         "slug" : "/wiki/food%20and%20drug%20administration",
         "name" : "U.S. Food and Drug Administration"
      },
      {
         "slug" : "/wiki/chemotherapy",
         "index" : 171,
         "name" : "chemotherapy"
      },
      {
         "name" : "daraxonrasib",
         "index" : 13,
         "slug" : "/wiki/daraxonrasib"
      },
      {
         "slug" : "/wiki/metastasis",
         "index" : 36,
         "name" : "metastatic"
      },
      {
         "slug" : "/wiki/pancreatic%20cancer",
         "index" : 70,
         "name" : "pancreatic cancer"
      }
   ],
   "images" : {},
   "changes" : [],
   "slug" : "/feed/2026/08/26/the-us-food-and-drug-administration-approves-the-daraxonrasib-drug-as-a-treatment-for-metastatic-pancreatic-cancer-ma",
   "text" : "The U.S. Food and Drug Administration approves the daraxonrasib drug as a treatment for metastatic pancreatic cancer, making it the first RAS inhibitor drug to be approved for the disease. This came after a previous study showed that it nearly doubled the survival rate for patients compared to chemotherapy. ",
   "keywords_list" : [
      "RAS inhibitor",
      "U.S. Food and Drug Administration",
      "chemotherapy",
      "daraxonrasib",
      "metastatic",
      "pancreatic cancer"
   ],
   "index" : 19,
   "date" : "2026-08-26",
   "related" : [
      {
         "score" : 1,
         "index" : 16,
         "date" : "2026-08-5",
         "changes" : [],
         "slug" : "/feed/2026/08/5/the-us-food-and-drug-administration-approves-moderna-s-mrna-influenza-vaccine-for-people-aged-50-and-older",
         "keywords" : [
            "U.S. Food and Drug Administration"
         ],
         "text" : "The U.S. Food and Drug Administration approves Moderna's mRNA influenza vaccine for people aged 50 and older. ",
         "hash" : "9cee690cca57282624b7eddd3c41fe69416f8bd3"
      },
      {
         "score" : 1,
         "slug" : "/feed/2026/07/27/the-us-food-and-drug-administration-approves-a-new-blood-test-for-colorectal-cancer-screenings-in-older-adults-includ",
         "date" : "2026-07-27",
         "index" : 31,
         "changes" : [],
         "text" : "The U.S. Food and Drug Administration approves a new blood test for colorectal cancer screenings in older adults, including those above age 45. ",
         "keywords" : [
            "U.S. Food and Drug Administration"
         ],
         "hash" : "332849d8c40c925954e817b2fd93d6fa2ed821d5"
      },
      {
         "score" : 1,
         "hash" : "b54a18fa5d5c7d60fdcac1d7e2fa566e3c61d332",
         "keywords" : [
            "U.S. Food and Drug Administration"
         ],
         "text" : "Taco Bell removes lettuce from some of their restaurants following reports that the Food and Drug Administration has opened an investigation into iceberg lettuce supplied to them. ",
         "changes" : [],
         "index" : 21,
         "slug" : "/feed/2026/07/16/taco-bell-removes-lettuce-from-some-of-their-restaurants-following-reports-that-the-food-and-drug-administration-has-ope",
         "date" : "2026-07-16"
      },
      {
         "hash" : "08b7e4eeb94cc9a90f31b643b495a9338e2ffecf",
         "text" : "A study published by \"The New England Journal of Medicine\" reports that the daraxonrasib, a RAS inhibitor drug that targets KRAS-mutated cancers, has doubled median overall survival in patients with metastatic pancreatic cancer as compared to chemotherapy. ",
         "keywords" : [
            "RAS inhibitor",
            "chemotherapy",
            "daraxonrasib",
            "metastatic",
            "pancreatic cancer"
         ],
         "changes" : [],
         "date" : "2026-05-31",
         "index" : 34,
         "slug" : "/feed/2026/05/31/a-study-published-by-the-new-england-journal-of-medicine-reports-that-the-daraxonrasib-a-ras-inhibitor-drug-that-targ",
         "score" : 5
      },
      {
         "date" : "2026-05-27",
         "index" : 26,
         "slug" : "/feed/2026/05/27/the-american-cancer-society-adds-the-fda-approved-guardant-health-shield-blood-test-to-its-recommended-colorectal-cancer",
         "changes" : [
            {
               "timestamp" : 1780177163,
               "hash" : "566ce44634aade8077a1ca5192ef0cce6f58a697",
               "text" : "The American Cancer Society announces that the Guardant Health Shield blood test, which was approved by the U.S. FDA in 2024, will be included as an option for colorectal cancer screenings in the United States. ",
               "slug" : "/feed/2026/05/27/the-american-cancer-society-announces-that-the-guardant-health-shield-blood-test-which-was-approved-by-the-us-fda-in",
               "date" : "2026-05-27"
            },
            {
               "hash" : "b5b9a1ee7fac146c529d0f0546f0f52e948c10f3",
               "timestamp" : 1780004330,
               "text" : "The American Cancer Society announces that the Guardant Health Shield blood test, which was approved by the U.S FDA in 2024, will be included as an option for colorectal cancer screenings amidst a rise in colon cancer cases in young adults. ",
               "slug" : "/feed/2026/05/27/the-american-cancer-society-announces-that-the-guardant-health-shield-blood-test-which-was-approved-by-the-us-fda-in-2",
               "date" : "2026-05-27"
            }
         ],
         "hash" : "b94292a0cb074f61e9f6ecfc47ed6eeefb8d7065",
         "keywords" : [
            "U.S. Food and Drug Administration"
         ],
         "text" : "The American Cancer Society adds the FDA-approved Guardant Health Shield blood test to its recommended colorectal cancer screening options in the United States amidst a rise in colon cancer cases in young adults. ",
         "score" : 1
      },
      {
         "hash" : "5361d19a5ca75e936f6e925bbf0a51f7a957c389",
         "text" : "The U.S. Food and Drug Administration approves Gilead Sciences's new lenacapavir drug, marketed as Yeztugo, for the treatment of HIV after successful clinical trials show the drug nearly eliminated the infection spread. ",
         "keywords" : [
            "U.S. Food and Drug Administration"
         ],
         "index" : 9,
         "changes" : [],
         "slug" : "/feed/2025/06/18/the-us-food-and-drug-administration-approves-gilead-sciences-s-new-lenacapavir-drug-marketed-as-yeztugo-for-the-trea",
         "date" : "2025-06-18",
         "score" : 1
      },
      {
         "score" : 1,
         "slug" : "/feed/2025/05/16/the-us-food-and-drug-administration-clears-the-fujirebio-lumipulse-for-distribution-the-first-blood-test-that-can-be",
         "changes" : [],
         "date" : "2025-05-16",
         "index" : 8,
         "hash" : "a2bf3b66f5ac78526d89fbba6299afd40412feb0",
         "keywords" : [
            "U.S. Food and Drug Administration"
         ],
         "text" : "The U.S. Food and Drug Administration clears the Fujirebio Lumipulse for distribution, the first blood test that can be used to diagnose Alzheimer's disease in people 55 years or older with memory problems by detecting amyloid plaques. Alzheimer's can currently only be diagnosed using a PET scan. "
      },
      {
         "score" : 1,
         "date" : "2025-04-15",
         "changes" : [],
         "index" : 11,
         "slug" : "/feed/2025/04/15/the-european-commission-approves-the-use-of-lecanemab-a-monoclonal-antibody-medication-that-targets-amyloid-beta-peptid",
         "keywords" : [
            "U.S. Food and Drug Administration"
         ],
         "text" : "The European Commission approves the use of Lecanemab, a monoclonal antibody medication that targets amyloid beta peptides, to treat the early stages of Alzheimer's disease via intravenous therapy. This is the first drug to be approved to treat the disease in Europe, and was approved by the Food and Drug Administration in the United States in 2023. ",
         "hash" : "63661837f50d925872ad990e0d169bd3556ffc67"
      },
      {
         "slug" : "/feed/2025/01/15/the-us-food-and-drug-administration-bans-the-usage-of-red-no-3-artificial-food-coloring-due-to-research-showing-that",
         "changes" : [],
         "index" : 12,
         "date" : "2025-01-15",
         "keywords" : [
            "U.S. Food and Drug Administration"
         ],
         "text" : "The U.S. Food and Drug Administration bans the usage of Red No. 3 artificial food coloring, due to research showing that the food coloring is carcinogenic. ",
         "hash" : "6a06ec438cce509580b2ea2007aca0dee2e99dcc",
         "score" : 1
      }
   ],
   "sources" : [
      {
         "year" : "2026",
         "name" : "Reuters",
         "permalink" : "https://www.reuters.com/legal/litigation/revolution-medicines-gets-fda-nod-targeted-pancreatic-cancer-drug-2026-08-26/",
         "hash" : "725232b5376d0e38f7e4fc48bb407950cc66691e",
         "month" : 8,
         "day" : "26"
      },
      {
         "day" : "26",
         "year" : "2026",
         "name" : "The Guardian",
         "hash" : "cf7ce08acf9d0534eb911b559b60ff977b58ba48",
         "month" : 8,
         "permalink" : "https://www.theguardian.com/us-news/2026/aug/26/fda-approves-new-pancreatic-cancer-drug"
      }
   ]
}